Mednet Logo
HomePediatric Hematology/OncologyQuestion

What is your surveillance protocol for patients with common variable immunodeficiency receiving chronic IVIG therapy?

1
1 Answers
Mednet Member
Mednet Member
Allergy & Immunology · University Hospitals Cleveland Medical Center

No target IgG level per se- dose/interval should be titrated to clinical condition. In general, trough IgG on treatment should be higher than 500 mg/dL, or 500 mg/dL higher than baseline. Most patients will not be in optimal clinical condition (minimal fatigue, arthralgias, absence of chronic cough,...

Register or Sign In to see full answer

What is your surveillance protocol for patients with common variable immunodeficiency receiving chronic IVIG therapy? | Mednet